Brainloop Home

ACADIA Pharmaceuticals is a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders.

"We chose Brainloop because of the product's unique ability to provide secure viewing and auditing functionality down to the page level. The security model is well thought through, adding users and sharing documents simple and secure. Reporting is easy to use yet powerful enough to provide meaningful insight."

Simon Craw, Senior Director of Information Systems and IT, ACADIA Pharmaceuticals, San Diego, CA

Zalicus unifies the strengths, assets and technologies of two companies, CombinatoRx and Neuromed, to discover and develop innovative therapeutics for patients in need. We believe that our novel product candidates, productive drug discovery platforms, drug development expertise, revenue-generating collaborations and financial resources provide a solid foundation for success.

"It was very easy to set up, and being able to share and protect files so easily really boosts efficiency. Plus, the support team has been terrific about responding to questions quickly."

Richard Brudnick, Vice President of Business Development, CombinatoRx Inc. (now Zalicus), Cambridge, MA

LANXESS is a leader in specialty chemicals with 2009 sales of EUR 5.06 billion and 14,300 employees in 23 countries. LANXESS has 42 production sites around the world. The company's core business comprises the development, manufacture and sale of plastics, rubber, specialty chemicals and intermediates.

"The way companies share information in the context of REACH processes is very highly variable and not always secure. That?s why we looked for a secure yet convenient platform to publish and share our valuable study results. REACH agreement processes are very time-consuming anyway, so we wanted this platform to make them significantly more efficient."

Dr. Bernd Woost, Information Technology, LANXESS Deutschland GmbH

Download case study

MediGene AG is a publicly listed (Frankfurt, Prime Standard: MDG, TecDAX) biotechnology company located in Martinsried / Munich, Germany, with subsidiaries in Oxford, UK and San Diego, USA. MediGene is the first German biotech company to have drugs on the market, which are being distributed by partner companies. MediGene has several drug candidates in clinical development, including EndoTAG?-1, which could offer substantial sales returns.

"Brainloop allows us to quickly exchange highly confidential information, such as current research results, reports and patent registrations with our collaboration partners on a revocable basis. At the same time, we can the secure document ownership in a controlled and supervised environment."

Dr. Markus Hörer, Director Research & Analytics, MediGene AG

As an independent marketing and sales company Midas Pharma brings together companies with different interests and capabilities. The objective: To be the partner of first choice for manufacturers and clients in all questions concerning Active Pharmaceutical Ingredients, Custom Synthesis, Pharmaceutical Contract Manufacture, International Licensing or Registration Dossiers.

"Brainloop helps us to distribute highly secure information to our partners in a safe, simple and user-friendly manner. Intelligent security categories and traceability allow us to precisely monitor who has done what with the documents and when."

Dr. Marcus Stumpf, Managing Director, Midas Pharma GmbH